Trial record 1 of 1 for:    NCT00526838
Previous Study | Return to List | Next Study

Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies

This study has been terminated.
(Sponsor decision)
Information provided by:
Exelixis Identifier:
First received: September 6, 2007
Last updated: April 4, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2011
  Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)